envelop
virus
encompass
common
human
pathogen
caus
infect
differ
sever
rang
symptom
lethal
diseas
seen
viral
hemorrhag
fever
envelop
virus
possess
envelop
membran
deriv
host
cell
modifi
often
heavili
glycosyl
viral
encod
glycoprotein
import
infect
viral
particl
format
immun
evas
nlink
glycosyl
viral
envelop
protein
well
character
respect
locat
structur
site
occup
inform
mucintyp
oglycosyl
protein
less
comprehens
studi
viral
glycosyl
often
limit
analysi
recombin
protein
case
produc
cell
line
glycosyl
capac
differ
capac
host
cell
glycosyl
pattern
produc
recombin
glycoprotein
might
therefor
differ
pattern
nativ
viral
protein
review
provid
histor
perspect
analysi
viral
glycosyl
summar
known
role
glycan
biolog
envelop
human
virus
addit
describ
overcom
analyt
limit
use
global
approach
base
mass
spectrometri
identifi
viral
oglycosyl
virusinfect
cell
lysat
use
complex
envelop
viru
herp
simplex
viru
type
model
underscor
glycan
often
pay
import
contribut
overal
protein
structur
function
immun
recognit
glycan
repres
crucial
determin
vaccin
design
high
throughput
analysi
glycosyl
relev
glycoprotein
formul
well
data
compil
share
therefor
import
identifi
consensu
glycosyl
pattern
translat
applic
envelop
virus
well
adapt
pathogen
infect
great
varieti
host
protozoan
mammal
hijack
host
cell
molecular
machineri
reproduct
intern
committe
taxonomi
virus
buchmann
holm
evolv
togeth
host
develop
variou
mean
counteract
host
defens
mechan
christiaansen
et
al
beachboard
horner
schuren
et
al
characterist
featur
virus
cell
membranederiv
envelop
modifi
viral
encod
protein
glycosyl
host
glycosyl
apparatu
pass
secretori
pathway
viral
glycoprotein
glycosyl
rel
site
other
dens
glycosyl
nlink
olink
glycan
promin
exampl
includ
ebola
viru
glycoprotein
modifi
high
content
olink
glycan
glycoprotein
glycosyl
addit
multipl
nlink
glycan
jeffer
et
al
pabst
et
al
yang
w
et
al
although
specif
function
role
assign
distinct
glycosit
multipl
virus
goffard
et
al
falkowska
et
al
hell
et
al
wang
et
al
wang
et
al
lennemann
et
al
bradeltretheway
et
al
luo
et
al
orlova
et
al
suenaga
et
al
stone
et
al
wu
et
al
gener
believ
high
level
glycosyl
serv
protect
shield
host
immun
system
francica
et
al
hell
et
al
sommerstein
et
al
behren
et
al
gram
et
al
wall
et
al
major
role
glycosyl
occur
viru
entri
glycan
host
cell
repres
viral
receptor
interact
carbohydr
bind
protein
viral
surfac
promin
exampl
influenza
virus
attach
surfac
glycan
resid
cellular
glycoprotein
air
hemagglutinin
ha
human
influenza
virus
use
sialic
acid
moieti
avian
virus
bind
preferenti
sialic
acid
air
apart
influenza
viru
sever
nonenvelop
human
virus
includ
adenovirus
reovirus
rotavirus
use
sialic
acidcontain
oligosaccharid
cell
receptor
stencelbaerenwald
et
al
sialic
acid
glycan
use
virus
cell
attach
exampl
flavivirus
human
respiratori
syncyti
viru
herpesvirus
use
proteoglycan
point
attach
cell
wherea
core
fucosyl
suggest
play
role
hbv
entri
hepatoma
cell
jolli
sattentau
takamatsu
et
al
import
aspect
host
glycan
receptor
viral
infect
review
cover
elsewher
jolli
sattentau
stencelbaerenwald
et
al
kim
et
al
instead
present
avail
inform
glycosyl
human
envelop
virus
discuss
gener
function
glycosyl
variou
aspect
viral
life
cycl
interact
immun
system
addit
discuss
human
herpesviru
glycosyl
detail
includ
conclus
emerg
recent
global
oglycoproteom
analys
glycosyl
viral
envelop
glycoprotein
depend
host
glycosyl
machineri
viral
glycoprotein
like
cellular
protein
possess
signal
peptid
direct
secretori
pathway
protein
target
secretori
pathway
decor
differ
kind
posttransl
modif
en
rout
cell
surfac
anoth
cellular
compart
glycosyl
one
widespread
versatil
modif
protein
classifi
n
oand
clink
name
acceptor
amino
acid
atom
sugar
moieti
attach
one
type
nlink
glycosyl
term
initi
mani
type
oglycosyl
exist
classifi
base
ident
initi
monosaccharid
stanley
moremen
et
al
type
oglycosyl
carri
secretori
pathway
cytosol
nuclear
protein
also
glycosyl
nacetylglucosamin
glcnac
cytosol
glycosyltransferas
moremen
et
al
yang
qian
type
oglycosyl
specif
distinct
class
protein
domain
moremen
et
al
haltom
jafarnejad
larsen
et
al
review
term
oglycosyl
refer
galnacor
mucintyp
oglycosyl
one
widespread
form
protein
oglycosyl
bennett
et
al
nlink
glycosyl
protein
acquir
cotransl
fold
endoplasm
reticulum
rothman
lodish
initi
glycan
moieti
compris
nine
mannos
man
three
glucos
glc
two
glcnac
residu
transfer
protein
dolicholphosphatelink
precursor
asparagin
residu
within
nxst
consensu
sequon
xall
amino
acid
except
p
robbin
et
al
baus
kornfeld
kornfeld
initi
glycan
structur
trim
man
glcnac
endoplasm
reticulum
intermedi
assist
protein
qualiti
control
hammond
et
al
heleniu
aebi
golgi
apparatu
glycan
trim
elong
branch
differenti
express
set
glycosidas
glycosyltransferas
yield
hybrid
complextyp
nglycan
hunt
et
al
rabouil
et
al
schachter
protein
pass
golgi
apparatu
also
modifi
mucintyp
oglycan
initi
famili
galnactransferas
add
initi
galnac
monosaccharid
ser
thr
possibl
tyr
residu
rottger
et
al
halim
et
al
bennett
et
al
galnactransferas
exhibit
somewhat
overlap
also
distinct
substrat
specif
express
isoenzym
regul
tissueand
differentiationspecif
manner
sutherlin
et
al
wandal
et
al
wandal
et
al
mandel
et
al
young
et
al
tian
ten
hagen
sinc
conserv
protein
sequenc
motif
gener
isoformspecif
oglycosyl
much
difficult
predict
modif
gerken
et
al
howev
predict
algorithm
exist
rapidli
improv
due
vast
increas
number
identifi
oglycosit
use
proteomewid
strategi
nevertheless
experiment
evid
still
requir
reliabl
site
identif
steentoft
et
al
olink
glycan
elong
compet
glycosyltransferas
form
eight
core
structur
add
heterogen
oglycosyl
imped
analysi
brockhausen
et
al
yeh
et
al
dalziel
et
al
schachter
although
mani
type
protein
glycosyl
exist
nand
mucintyp
olink
glycosyl
studi
viral
research
type
glycosyl
also
focu
follow
section
histor
herpesvirus
togavirus
first
virus
investig
modif
carbohydr
led
import
find
regard
gener
aspect
viral
glycosyl
earli
method
analysi
base
monitor
incorpor
radioact
label
monosaccharid
amino
acid
newli
synthes
viral
protein
infect
keller
et
al
spear
roizman
kim
et
al
therebi
establish
viral
protein
glycosyl
took
place
cellular
membran
cytoplasm
compart
earli
glycoprofil
experi
util
pronas
digest
label
glycoprotein
follow
gel
filtrat
allow
separ
short
glycopeptid
bear
differ
glycan
moieti
honess
roizman
schwarz
et
al
moreov
differenti
label
sugar
use
provid
insight
put
composit
individu
glycan
structur
sefton
import
conclus
base
experi
extent
sugar
incorpor
individu
viral
protein
differ
depend
infect
cell
type
keller
et
al
establish
virus
depend
host
glycosyl
machineri
use
glycosyl
inhibitor
tunicamycin
glucosamin
provid
addit
insight
regul
glycan
synthesi
impact
viral
replic
show
glycosyl
viral
protein
critic
infect
cellcel
fusion
knowl
person
leavitt
et
al
olofsson
lyck
herrler
compan
lambert
pon
mann
et
al
studi
cell
line
defici
specif
glycosyltransferas
intracellular
transport
inhibitor
provid
addit
mean
investig
biolog
consequ
disrupt
glycan
synthesi
matur
respect
campadellifium
et
al
edwardson
alongsid
numer
studi
address
viral
nglycan
composit
function
discov
viral
envelop
glycoprotein
could
also
modifi
olink
glycan
olofsson
et
al
shida
dale
niemann
et
al
gruber
levin
montalvo
et
al
gong
et
al
lundstrom
et
al
human
protein
golgi
apparatu
identifi
site
viral
oglycosyl
johnson
spear
locker
et
al
histor
presum
virus
oglycosyl
function
modif
remain
undetermin
time
feldmann
et
al
bernstein
et
al
one
first
function
viral
oglycosyl
discov
vaccinia
viru
demonstr
hemagglutin
activ
glycoprotein
ha
entir
depend
olink
glycan
shida
dale
similar
carbohydratedepend
function
describ
rubella
viru
treatment
mix
glycosidas
remov
glycan
result
inhibit
hemagglutin
hoterri
cohen
develop
new
biochem
method
facilit
isol
analysi
viral
glycoprotein
glycan
use
plant
lectin
sera
immun
anim
well
vaccin
patient
facilit
purif
viral
envelop
protein
enabl
analysi
glycan
individu
protein
level
eisenberg
et
al
wensk
et
al
friedrich
grose
respess
et
al
montalvo
et
al
introduct
chemic
glycan
releas
peptid
sequenti
enzymat
deglycosyl
enabl
precis
character
viral
glycan
size
composit
compar
pronas
digest
burk
keegstra
rasilo
renkonen
led
determin
type
structur
nand
olink
glycan
mani
virus
pesonen
pesonen
ronnholm
et
al
niemann
et
al
subsequ
introduct
revers
phase
hplc
facilit
glycopeptid
analysi
allow
separ
larger
glycopeptid
gener
digest
protein
proteas
defin
specif
trypsin
subsequ
enzymat
glycan
releas
enabl
nglycan
analysi
isol
glycopeptid
rosner
robbin
cohen
et
al
hsieh
et
al
demonstr
sitespecif
glycan
microheterogen
differ
host
hsieh
et
al
develop
advanc
mass
spectrometrybas
applic
larg
impact
analysi
glycan
quickli
adopt
virolog
field
recent
advanc
mass
spectrometrybas
glycoprofil
glycoproteom
envelop
virus
discuss
follow
section
modern
mass
spectrometrybas
method
analysi
enabl
robust
character
olink
glycan
complex
biolog
sampl
unpreced
sensit
resolut
becom
routin
practic
character
recombin
therapeut
well
vaccin
candid
xie
et
al
dubayl
et
al
jacob
et
al
matrixassist
laser
desorptionion
mass
spectrometri
maldim
one
commonli
use
tool
modern
day
glycan
analysi
combin
maldim
lectin
microarray
enabl
reliabl
character
glycan
structur
lectin
bind
profil
provid
addit
inform
glycosid
linkag
mechref
et
al
lei
et
al
moreov
tandem
maldim
tandem
electrospray
ioniz
ms
allow
fragment
select
precursor
ion
enabl
detail
character
structur
given
composit
mechref
et
al
ritchi
et
al
techniqu
soon
adapt
analysi
nglycan
recombin
viral
protein
matur
viral
particl
appli
mass
spectrometrybas
analysi
viral
glycan
releas
matur
viral
particl
illustr
heterogen
nglycan
structur
present
singl
protein
exampl
detail
studi
dengu
virion
reveal
enorm
heterogen
nglycan
structur
modifi
two
put
site
dengu
viru
glycoprotein
distinct
structur
identifi
lei
et
al
addit
msbase
glycoprofil
demonstr
distinct
glycosyl
pattern
differ
host
speci
chikungunya
viru
lancast
et
al
confirm
earlier
observ
togavirus
hsieh
et
al
maldim
also
use
compar
glycan
profil
recombinantli
express
viral
protein
protein
isol
nativ
virus
comparison
nglycan
profil
recombin
monom
trimer
present
nativ
virus
reveal
monomer
recombin
protein
contain
high
proport
complextyp
glycan
nativ
trimer
preserv
protein
quaternari
structur
predominantli
contain
highmannos
type
carbohydr
door
bonomelli
et
al
bonomelli
et
al
highmannos
type
glycan
consist
found
monomer
trimer
formul
part
intrins
mannos
patch
contain
dens
space
underprocess
glycan
bonomelli
et
al
contrast
analysi
dimer
viral
glycoprotein
hendra
viru
suggest
oligomer
alway
imped
glycan
process
bowden
et
al
viral
protein
architectur
howev
requir
recapitul
physiolog
relev
glycosyl
repertoir
glycosyltransferas
natur
also
play
import
role
exampl
nglycan
pseudovirion
cell
line
mainli
carri
sialic
acid
nglycan
virion
deriv
peripher
blood
mononuclear
cell
predominantli
carri
sialic
acid
pritchard
harvey
et
al
differ
might
huge
implic
immunogen
recombin
vaccin
antigen
given
broadli
neutral
antibodi
recogn
glycancontain
epitop
mouquet
et
al
mccoy
burton
therefor
antigen
formul
product
cell
line
must
consid
care
anoth
concern
analyz
recombin
viral
protein
sourc
inform
viral
glycosyl
occasion
need
artifici
formul
recombin
viral
protein
often
lack
natur
process
oligomer
signal
assembl
present
viral
context
bowden
et
al
ritchi
et
al
exampl
shown
lack
proteolyt
cleavag
membranetrunc
solubl
envelop
glycoprotein
result
aberr
glycosyl
alter
conform
trimer
alsalmi
et
al
ebola
viru
glycoprotein
repres
anoth
exampl
highli
elabor
protein
complex
assembl
exist
three
distinct
speci
due
transcript
stutteringsgp
gp
ssgptwo
secret
lee
saphir
membran
bound
gp
proteolyt
process
form
trimer
cell
surfac
lee
saphir
nevertheless
formul
gp
differ
natur
viral
context
pursu
glycoanalysi
nglycan
analysi
perform
solubl
fragment
sgp
exhibit
mix
complex
hybrid
highmannos
structur
sgp
carri
higher
proport
process
structur
ritchi
et
al
recent
glycoprofil
stabil
monomer
construct
five
differ
strain
ebola
viru
confirm
presenc
heterogen
mostli
complextyp
nglycan
collar
et
al
contrast
highli
variabl
oglycan
pattern
differ
strain
collar
et
al
recombin
glycoprotein
nipah
viru
machupo
viru
express
monomer
form
report
predominantli
carri
complextyp
nglycan
bowden
et
al
bowden
et
al
conclus
difficult
predict
glycosyl
pattern
nativ
oligomer
protein
complex
base
studi
recombin
monomer
protein
howev
sometim
solut
difficulti
express
correctli
fold
authent
protein
complex
maldim
also
appli
oglycan
analysi
cani
et
al
franc
et
al
howev
wide
use
virolog
field
exampl
oglycoprofil
viral
glycoprotein
use
maldim
exist
collar
et
al
probabl
explain
lower
interest
viral
oglycosyl
oppos
nglycosyl
primarili
due
poorli
character
function
viral
oglycan
presumpt
viral
glycoprotein
heavili
oglycosyl
addit
sophist
method
allow
simultan
determin
modifi
amino
acid
rapidli
taken
recent
year
wide
use
analysi
viral
oglycosyl
glycoprofil
studi
provid
import
inform
distribut
composit
differ
glycan
structur
present
given
protein
lack
inform
individu
glycosit
locat
occup
glycan
structur
heterogen
recent
develop
instrument
equip
ecd
etd
fragment
allow
simultan
determin
peptid
sequenc
posit
carbohydr
moieti
attach
leveri
et
al
relev
report
glycan
oxonium
ion
present
easi
predict
glycosyl
posit
within
peptid
hcd
fragment
also
use
wuhrer
et
al
interfac
mass
spectromet
capillari
liquid
chromatographi
enabl
separ
complex
proteomescal
glycopeptid
mixtur
allow
identif
thousand
glycopeptid
singl
run
singl
protein
level
possibl
determin
exact
posit
structur
heterogen
site
occup
individu
glycosit
wuhrer
et
al
nand
oglycosyl
analyz
tandem
ms
biosynthet
featur
nglycosyl
enabl
rel
easi
identif
quantif
deglycosyl
site
sequenc
due
asparagin
deamid
enzymat
nglycan
remov
site
occup
determin
calcul
intens
ratio
nake
asn
deglycosyl
asp
peptid
pabst
et
al
et
al
howev
appropri
methodolog
includ
carri
reaction
use
heavyoxygen
water
h
discrimin
deglycosyl
site
spontan
asn
deamid
palmisano
et
al
cao
et
al
also
possibl
evalu
overal
distribut
nglycosit
occup
intact
glycoprotein
metabol
simplifi
glycan
homogen
structur
struw
et
al
olink
glycan
complet
oglycan
remov
result
chemic
peptid
modif
use
identif
glycosyl
amino
acid
posit
leveri
et
al
etd
ecd
techniqu
allow
analysi
intact
oglycopeptid
fragment
peptid
backbon
without
loss
oglycan
modif
howev
limit
use
determin
site
occup
wuhrer
et
al
sihlbom
et
al
zauner
et
al
approxim
yet
often
made
compar
intens
nonmodifi
glycosyl
peptid
brautigam
et
al
stansel
et
al
rel
quantit
nand
oglycosyl
peptid
accur
due
differ
ioniz
effici
nonglycosyl
peptid
peptid
carri
complex
glycan
depend
complex
glycan
glycopeptid
gener
exhibit
poorer
ioniz
compar
peptid
stavenhagen
et
al
analysi
complex
protein
therefor
often
requir
enrich
hydrophil
interact
chromatographi
specif
lectin
particularli
relev
proteomewid
applic
bunkenborg
et
al
zielinska
et
al
khatri
et
al
leveri
et
al
howev
inform
regard
site
occup
need
sacrif
tandem
mass
spectrometri
wide
use
character
nglycosyl
site
viral
protein
respect
individu
site
occup
statu
macroheterogen
sitespecif
structur
divers
microheterogen
import
featur
affect
proteinprotein
interact
immunogen
comprehens
glycoproteom
analysi
exampl
map
nlink
glycosyl
season
influenza
viru
ha
identifi
site
occup
put
nlink
glycan
site
moreov
globular
head
glycosit
associ
host
immun
receptor
interact
strictli
highmannos
type
separ
studi
highli
pathogen
influenza
viru
also
shown
potenti
nglycosit
consist
occupi
sever
differ
strain
blake
et
al
suggest
nglycosyl
ha
conserv
differ
isol
viru
subtyp
high
occup
potenti
nglycosit
similar
way
demonstr
predict
nglycan
sequon
util
hepat
c
viru
murray
valley
enceph
viru
blitvich
et
al
iacob
et
al
major
hcv
glycosit
modifi
highmannos
type
glycan
iacob
et
al
dens
glycosyl
envelop
glycoprotein
sever
strategi
employ
character
natur
locat
mani
glycan
mostli
highli
occupi
nglycosit
identifi
exclus
highmannos
type
pabst
et
al
go
et
al
yang
w
et
al
tandem
mass
spectrometri
also
use
address
differ
celltyp
specif
glycosyl
influenc
protein
conform
conveni
solubl
prepar
often
analyz
produc
cho
cell
similar
occup
degre
fucosyl
sialyl
glycan
matur
larger
share
glycosit
predominantli
carri
hybrid
complextyp
nglycan
go
et
al
posit
exclus
highmannos
nglycan
locat
within
intrins
mannos
patch
go
et
al
behren
et
al
contrast
much
higher
proport
nglycosit
express
cho
recombin
trimer
purifi
nativ
virion
modifi
highmannos
type
nglycan
pabst
et
al
behren
et
al
panico
et
al
go
et
al
signifi
import
analyz
nativ
protein
conform
gener
relev
glycosyl
pattern
glycosyl
differ
cell
line
also
investig
hendra
viru
recombin
glycoprotein
g
seven
potenti
nglycan
site
occupi
hela
cell
colgrav
et
al
contrast
four
site
nglycosyl
although
degre
glycan
matur
similar
cell
line
colgrav
et
al
summar
result
obtain
variou
nglycoprofil
glycoproteom
studi
seem
put
nglycosyl
sequon
glycosyl
high
occup
viral
protein
howev
site
occup
viral
protein
nglycosyl
vari
differ
produc
cell
line
moreov
highmannos
type
nglycan
may
constitut
substanti
major
proport
viral
nglycosit
particularli
nativ
protein
structur
oligomer
taken
account
thu
result
obtain
analysi
recombin
monomer
protein
interpret
caution
also
consid
occup
individu
nglycosyl
site
well
complex
glycan
structur
discuss
decad
littl
inform
avail
regard
sitespecif
oglycosyl
viral
protein
first
describ
virusderiv
sitespecif
oglycan
isoform
hbv
surfac
antigen
purifi
patientderiv
viral
particl
oglycosyl
site
identifi
combin
maldi
analysi
exoglycosidasetr
glycopeptid
edman
sequenc
underli
peptid
posit
glycan
attach
site
deduc
carboxypeptidas
digest
confirm
collisioninduc
dissoci
tandem
mass
spectrometri
repres
earli
glycoproteom
experi
viral
protein
recent
advanc
mass
spectrometrybas
proteom
result
numer
studi
address
oglycosyl
individu
viral
glycoprotein
oglycoproteom
analys
perform
sever
recombin
isol
viral
glycoprotein
includ
influenza
viru
hcv
gc
hendra
viru
glycoprotein
g
colgrav
et
al
brautigam
et
al
go
et
al
yang
w
et
al
norden
et
al
stansel
et
al
recombinantli
express
glycosyl
singl
posit
case
modifi
core
core
elong
oglycan
stansel
et
al
interestingli
site
occup
much
lower
recombin
undergo
proteolyt
cleavag
assum
equival
ioniz
effici
nonmodifi
glycosyl
peptid
recombin
possess
shorter
less
sialyl
predominantli
core
oglycan
underlin
import
nativ
protein
conform
analog
studi
stansel
et
al
contrast
purifi
tcell
deriv
virion
devoid
singl
site
found
glycosyl
recombinantli
express
stansel
et
al
howev
might
relat
viral
strain
use
singl
site
report
glycosyl
separ
studi
use
virion
differ
strain
yang
w
et
al
addit
treatment
passag
plasmaderiv
virion
antibodi
olink
carbohydr
structur
result
inhibit
cell
entri
viru
neutral
hansen
et
al
hansen
et
al
suggest
inde
oglycosyl
vivo
comparison
recombin
oglycosyl
two
differ
cell
line
reveal
predomin
core
oglycosyl
cho
cell
compar
core
core
core
cell
go
et
al
similar
manner
hendra
viru
glycoprotein
g
express
hela
cell
differ
consider
differ
number
oglycosit
identifi
carri
differ
core
structur
colgrav
et
al
recombin
hcv
oglycosyl
six
posit
predominantli
core
core
oglycan
structur
brautigam
et
al
occup
estim
five
six
site
wherea
one
site
low
occup
moreov
high
level
structur
heterogen
observ
oglycan
local
individu
site
differ
structur
identifi
brautigam
et
al
recent
studi
olink
glycosyl
mucinlik
protein
gc
provid
insight
oglycan
synthesi
suggest
eleven
oglycosit
ad
orderli
fashion
elong
took
place
studi
underscor
high
heterogen
oglycan
structur
cell
type
protein
specif
need
care
select
candid
express
cell
line
clinic
applic
moreov
comprehens
analysi
immun
respons
mount
differ
structur
would
highli
benefici
clear
singl
proteintarget
mass
spectrometri
approach
provid
comprehens
inform
singl
site
occup
structur
heterogen
lack
robust
method
analysi
sitespecif
oglycosyl
complex
proteomewid
sampl
solv
problem
recent
introduc
method
global
map
oglycosyl
site
glycoengin
cell
line
lack
olink
glycan
elong
base
vicia
villosa
lectin
vva
affin
enrich
simpl
glycopeptid
coupl
tandem
mass
spectrometri
steentoft
et
al
method
also
applic
analysi
wild
type
cell
predominantli
express
core
oglycan
use
peanut
agglutinin
pna
enrich
desialyl
glycopeptid
yang
z
et
al
appli
method
analysi
oglycosyl
infect
human
fibroblast
perform
sequenti
enrich
pna
vva
thu
report
first
comprehens
viral
oglycoproteom
bagdonait
et
al
approach
provid
sever
clear
advantag
first
allow
simultan
analysi
viral
glycoprotein
express
infect
cell
secondli
strategi
take
account
endogen
glycosyl
permiss
cell
dictat
repertoir
glycosyltransferas
well
nativ
conform
protein
cytopath
effect
viral
infect
irrelev
cell
line
often
chosen
recombin
express
viral
protein
glycosyl
obtain
cell
line
alway
reflect
glycosyl
pattern
natur
host
use
herpesvirus
model
system
appli
method
defin
oglycoproteom
member
herpesvirida
vzv
hcmv
ebv
iversen
et
al
wide
occurr
associ
complic
shortag
prophylact
measur
make
herpesvirus
relev
model
system
analyz
oglycan
import
viral
life
cycl
vazquez
et
al
cohen
et
al
adjei
et
al
kramer
et
al
oxman
shiley
blumberg
lopo
et
al
sauerbrei
et
al
levin
et
al
van
rijckevorsel
et
al
astuto
et
al
condeglez
et
al
fishman
gorfinkel
et
al
odland
et
al
pembrey
et
al
row
et
al
shaiegan
et
al
addit
larg
proteom
herpesvirus
highlight
benefit
global
viral
oglycoproteom
human
herpesvirus
encod
seven
glycoprotein
associ
viral
particl
howev
mani
viral
protein
possess
signal
peptid
transit
host
secretori
pathway
previous
investig
glycan
modif
focus
studi
nlink
glycan
identifi
viral
envelop
glycoprotein
human
herpesvirus
wensk
et
al
edson
thorleylawson
friedrich
grose
serafinicessi
et
al
montalvo
et
al
grose
gong
et
al
britt
vugler
gong
kieff
okuno
et
al
okuno
et
al
foatomasi
et
al
nolan
morgan
pfeiffer
et
al
hata
et
al
mukai
et
al
chandran
et
al
pertel
et
al
huber
compton
li
et
al
zhu
et
al
baghian
et
al
skrincoski
et
al
wu
et
al
maresova
et
al
theiler
compton
koyano
et
al
paulsen
et
al
yamagishi
et
al
gore
huttfletch
luo
et
al
individu
glycoprotein
demonstr
exhibit
variabl
extent
pattern
glycan
chain
matur
wensk
et
al
edson
thorleylawson
friedrich
grose
serafinicessi
et
al
montalvo
et
al
grose
britt
vugler
gong
kieff
okuno
et
al
okuno
et
al
huber
compton
maresova
et
al
theiler
compton
yamagishi
et
al
rel
smaller
proport
envelop
glycoprotein
herpesvirus
investig
term
oglycosyl
envelop
protein
oglycan
detect
biochem
assay
serafinicessi
dallolio
scannavini
costanzo
et
al
montalvo
et
al
gong
et
al
montalvo
grose
serafinicessi
et
al
britt
vugler
kari
et
al
yao
et
al
nolan
morgan
borza
huttfletch
cardinali
et
al
lake
et
al
peng
et
al
torrisi
et
al
zhu
et
al
wu
et
al
theiler
compton
xiao
et
al
protein
merit
thorough
investig
attent
devot
protein
contain
mucinlik
domain
attach
factor
gc
first
envelop
glycoprotein
describ
carri
oglycan
acquir
distinct
structur
differ
cell
type
olofsson
et
al
olofsson
et
al
dallolio
et
al
lundstrom
et
al
specif
oglycosit
recent
map
mucinlik
region
bagdonait
et
al
norden
et
al
furthermor
vzv
ortholog
also
found
oglycosyl
zezulak
spear
bagdonait
et
al
similarli
mucinlik
regioncontain
protein
gi
gg
ebv
shown
accommod
high
densiti
oglycosyl
type
oglycan
structur
identifi
protein
nolan
morgan
borza
huttfletch
norberg
et
al
conserv
viral
fusion
effector
gb
shown
predict
oglycosyl
herpesviru
subfamili
serafinicessi
dallolio
scannavini
costanzo
et
al
gong
et
al
montalvo
grose
britt
vugler
era
proteomewid
mass
spectrometrybas
applic
allow
robust
character
viral
oglycoproteom
bagdonait
et
al
iversen
et
al
character
confirm
ident
major
previous
describ
oglycoprotein
herpesvirus
provid
tremend
expans
sitespecif
oglycosyl
bagdonait
et
al
iversen
et
al
galnactyp
oglycosyl
often
associ
dens
glycosyl
mucinlik
region
also
abundantli
found
isol
small
cluster
human
protein
steentoft
et
al
difficult
predict
agreement
demonstr
ampl
presenc
isol
oglycan
site
viral
glycoprotein
vzv
hcmv
ebv
glycoproteom
approach
bagdonait
et
al
iversen
et
al
locat
oglycosit
identifi
via
proteomewid
msm
approach
respect
protein
structur
featur
suggest
possibl
involv
proteinprotein
interact
bagdonait
et
al
exemplifi
subsequ
section
larg
scale
glycoproteom
analys
human
herpesvirus
vari
phylogeni
vzv
hcmv
ebv
made
possibl
compar
oglycosit
pattern
homolog
protein
bagdonait
et
al
iversen
et
al
comparison
oglycosit
conserv
alphaherpesvirus
suggest
sequenc
homolog
import
determin
oglycosyl
close
relat
virus
figur
f
isol
homolog
glycosit
mainli
situat
highli
homolog
peptid
stretch
wherea
dens
space
glycosit
proserthrrich
region
glycosyl
irrespect
low
sequenc
ident
expect
sever
glycoprotein
homolog
herpesvirus
includ
gb
gh
gl
gm
gn
gb
gh
gl
compris
conserv
cell
entri
machineri
mcgeoch
et
al
identifi
larg
number
oglycosit
fusogen
effector
gb
predict
number
oglycosit
could
conserv
human
herpesvirus
figur
c
base
multipl
sequenc
align
across
investig
herpesviru
famili
member
enrich
oglycosyl
found
extrem
nterminu
gb
regardless
underli
consider
sequenc
variat
differ
herpesvirus
suggest
glycosyl
patch
less
depend
underli
sequenc
might
serv
glycan
specif
function
protect
ntermin
expos
region
gb
proteolyt
degrad
immun
recognit
contrast
conserv
singl
glycosit
predominantli
found
smaller
extent
vzv
suggest
mainli
exert
subfamilyspecif
function
conserv
protein
gh
anoth
essenti
compon
fusion
machineri
found
glycosyl
four
five
investig
virus
although
clear
conserv
pattern
glycosyl
observ
oglycosit
predominantli
local
two
expos
ntermin
domain
involv
interact
viral
protein
figur
e
summari
global
oglycoproteom
virus
open
possibl
rapidli
scan
proteom
virus
oglycan
modif
although
occup
relev
individu
glycan
site
still
unknown
inform
use
follow
complimentari
techniqu
individu
protein
glycosit
level
appli
human
viru
interest
given
relev
propag
system
avail
method
cours
limit
limit
number
glycoform
captur
well
avail
protein
sequenc
databas
challeng
analyz
emerg
poorli
annot
virus
well
clinic
isol
anoth
aim
futur
make
result
broadli
avail
scientif
commun
mean
publish
also
inclus
public
protein
databas
ideal
viru
databas
compil
structur
data
sequenc
variabl
avail
glycom
glycoproteom
data
well
antigen
site
could
creat
advanc
basic
appli
research
virolog
suffici
experiment
data
compil
machin
learn
bioinformat
techniqu
could
appli
predict
glycosyl
pattern
emerg
viral
strain
within
distinct
viru
speci
even
famili
glycan
viral
envelop
glycoprotein
play
import
role
viru
biolog
specif
function
identifi
variou
stage
viral
infect
tabl
figur
previous
mention
glycosyl
gener
requir
progeni
format
infect
mani
virus
knowl
person
leavitt
et
al
olofsson
lyck
herrler
compan
lambert
pon
mann
et
al
kuhn
et
al
li
et
al
reszka
et
al
mathi
balzarini
shrivastavaranjan
et
al
mossenta
et
al
case
matur
nglycan
particular
necessari
proper
viral
particl
format
releas
datema
et
al
human
protein
nlink
glycosyl
critic
proper
fold
viral
protein
land
braakman
zai
et
al
wu
et
al
case
viral
protein
secret
hu
et
al
lu
et
al
yoshii
et
al
mossenta
et
al
drug
target
glycoprotein
matur
exhibit
favor
therapeut
ratio
therefor
use
combat
viral
infect
therapeut
avail
miller
et
al
importantli
nand
olink
glycan
shield
immunodomin
epitop
immun
recognit
francica
et
al
hell
et
al
sommerstein
et
al
behren
et
al
gram
et
al
wall
et
al
addit
gener
function
specif
type
glycan
viral
glycoprotein
often
affect
receptor
bind
cell
fusion
lin
et
al
lozach
et
al
gramberg
et
al
davi
et
al
miller
et
al
chen
et
al
phoenix
et
al
wang
et
al
moreov
becom
increasingli
clear
distinct
glycan
play
separ
role
variou
stage
viral
cycl
goffard
et
al
falkowska
et
al
hell
et
al
wang
et
al
wang
et
al
lennemann
et
al
bradeltretheway
et
al
luo
et
al
orlova
et
al
wu
et
al
sitespecif
function
viral
glycosyl
assign
nand
olink
glycan
mostli
sitedirect
mutagenesi
studi
identifi
role
glycan
within
variou
stage
viral
cycl
discuss
follow
section
number
virus
hcv
dengu
viru
ebola
viru
sar
coronaviru
west
nile
viru
rift
valley
fever
viru
japanes
enceph
viru
use
nlink
glycan
attach
entri
receptor
interact
cellular
lectin
dcsign
lsign
lsectin
asgpr
mannos
receptor
becker
et
al
lin
et
al
lozach
et
al
gramberg
et
al
davi
et
al
miller
et
al
chen
et
al
phoenix
et
al
wang
et
al
matur
nglycan
suggest
influenc
lassa
viru
bind
cell
entri
receptor
shrivastavaranjan
et
al
addit
specif
nglycan
shown
affect
receptor
bind
cell
regul
coreceptor
usag
nakayama
et
al
pollaki
et
al
francoi
balzarini
lombardi
et
al
system
function
analysi
potenti
nglycosyl
site
identifi
number
addit
glycosit
affect
infect
addit
certain
nglycan
shown
consist
effect
sever
viral
strain
mathi
balzarini
specif
sialyl
nglycan
vzv
gb
identifi
import
interact
myelinassoci
glycoprotein
crucial
cellcel
fusion
suenaga
et
al
sialyl
virion
gener
shown
affect
entri
teuton
brandt
similarli
specif
nlink
glycan
gb
influenc
viral
entri
luo
et
al
nglycosyl
site
iav
ha
also
shown
affect
viral
entri
indirectli
modul
avid
specif
sialosid
wu
et
al
final
distinct
put
nglycosyl
site
mutat
hcv
result
diminish
entri
alter
bind
goffard
et
al
falkowska
et
al
hell
et
al
contrast
rather
well
document
role
nlink
glycan
known
exampl
specif
oglycan
particip
virushost
interact
among
two
sialyl
oglycan
gb
identifi
determin
bind
cellular
receptor
pair
immunoglobulinlik
type
receptor
resid
immun
cell
wang
et
al
arii
et
al
bagdonait
et
al
addit
oglycan
involv
aspect
viral
bind
host
cell
delet
dens
oglycosyl
region
attach
factor
gc
affect
bind
affin
cell
surfac
releas
progeni
viru
via
modul
interact
cell
surfac
glycosaminoglycan
altgard
et
al
anoth
exampl
includ
carbohydratedepend
bind
filovirus
macrophag
galactos
lectin
known
recogn
galnacoglycan
takada
et
al
hepat
c
viru
mutat
sever
put
oglycosit
also
shown
decreas
hcv
affin
suggest
oglycan
might
gener
import
mediat
interact
host
cell
falkowska
et
al
oglycoproteom
analysi
hendra
viru
glycoprotein
g
recent
sprout
first
best
knowledg
systemat
function
analysi
known
oglycosyl
site
reveal
multitud
function
includ
attach
entri
host
cell
colgrav
et
al
stone
et
al
importantli
function
could
also
identifi
analog
oglycosit
close
relat
nipah
viru
stone
et
al
interestingli
nipah
viru
singl
oglycosit
significantli
affect
ephrin
receptor
bind
stone
et
al
import
exampl
conserv
oglycan
function
close
relat
virus
present
intrigu
possibl
light
recent
identifi
consist
oglycosyl
pattern
sever
herpesvirus
besid
confirm
oglycosit
involv
bind
vitro
oglycosit
resid
protein
region
expect
influenc
attach
via
cell
entri
receptor
hvem
carfi
et
al
krummenach
et
al
heldwein
et
al
di
giovin
et
al
gallagh
et
al
vzv
attach
receptor
insulin
degrad
enzym
berarducci
et
al
identifi
bagdonait
et
al
anoth
exampl
msbase
approach
combin
structur
knowledg
help
narrow
list
oglycosit
candid
focus
studi
conclus
glycan
viral
entri
protein
wide
use
modul
receptor
bind
entri
nlink
olink
glycan
capac
affect
interact
figur
top
left
panel
case
though
seem
effect
conform
stabil
rather
direct
interact
stone
et
al
specif
nglycosit
identifi
import
glycoprotein
secret
viral
particl
format
virus
includ
zika
viru
hepat
virus
b
c
hbv
hcv
fournilli
et
al
falkowska
et
al
hell
et
al
ito
et
al
wang
et
al
luo
et
al
mossenta
et
al
nglycosit
influenza
viru
neuraminidas
shown
affect
protein
activ
viral
particl
releas
wu
et
al
also
well
document
nlink
glycosyl
alphaherpesviru
envelop
protein
requir
traffick
cell
surfac
viral
particl
egress
norrild
pedersen
montalvo
et
al
luo
et
al
suenaga
et
al
particular
complextyp
nglycan
requir
robust
egress
varicella
zoster
viru
role
potenti
oglycosyl
site
also
address
sitedirect
mutagenesi
sever
glycosit
found
affect
cell
surfac
express
protein
howev
approach
labori
analysi
potenti
oglycosyl
site
given
lack
conserv
sequenc
motif
oglycosyl
suenaga
et
al
target
approach
sitedirect
mutagenesi
oglycosit
hendra
viru
glycoprotein
g
identifi
via
oglycoproteom
approach
affect
incorpor
glycoprotein
f
pseudotyp
virion
suggest
oglycan
might
requir
proteinprotein
interact
stone
et
al
similarli
hiv
oglycosyl
conserv
threonin
crucial
associ
recent
shown
enhanc
infect
incorpor
virion
though
viru
maintain
normal
function
absenc
oglycan
termini
et
al
conclus
manipul
glycan
glycosyl
site
seem
affect
virus
use
direct
bud
use
exocytosi
therefor
like
glycan
affect
mani
differ
aspect
viral
particl
format
figur
bottom
right
panel
possibl
indirect
consequ
disrupt
traffick
glycoprotein
requir
viru
format
stone
et
al
mossenta
et
al
differ
virus
employ
variou
spread
mechan
system
within
site
infect
includ
cellcel
fusion
transmigr
neuroinvas
virus
often
take
advantag
compon
innat
immun
system
target
cell
type
interest
distant
locat
glycan
play
import
role
mechan
figur
bottom
left
panel
deadli
hendra
viru
globular
head
region
glycoprotein
g
import
bind
entri
receptor
ephrin
mutat
nglycosyl
site
globular
head
glycoprotein
g
increas
cellcel
fusion
wherea
remov
glycosit
stalk
region
hendra
glycoprotein
g
abolish
cellcel
fusion
bradeltretheway
et
al
case
oglycan
howev
remov
distinct
oglycosit
within
cluster
stalk
region
result
hypoand
hyperfusogen
phenotyp
stone
et
al
neither
nnor
oglycosit
mutant
exhibit
impair
receptor
bind
bradeltretheway
et
al
stone
et
al
suggest
glycan
influenc
aspect
membran
fusion
possibl
affect
thermodynam
conform
chang
impact
nglycan
viral
spread
also
demonstr
vivo
model
interestingli
glycosyl
statu
west
nile
viru
glycoprotein
associ
neuroinvas
abolish
glycosit
led
attenu
whiteman
et
al
similarli
loss
nglycosit
ross
river
viru
glycoprotein
associ
milder
pathogenesi
increas
viru
clearanc
diseas
mous
model
nelson
et
al
final
specif
nglycosyl
pattern
ha
na
avian
influenza
viru
requir
effici
transmiss
mammalian
model
park
et
al
direct
role
glycan
emerg
viral
exploit
innat
immun
receptor
help
hand
establish
viral
infect
innat
immun
receptor
secret
glycan
bind
protein
present
infect
host
cell
antigen
present
cell
natur
first
line
defens
invad
pathogen
instanc
secret
ctype
lectin
mannosebind
lectin
inhibit
hcv
entri
hepatocyt
brown
et
al
zhao
et
al
howev
carbohydr
bind
protein
convey
protect
deleteri
effect
viral
infect
exploit
virus
enter
host
cell
exampl
secret
promot
entri
nipah
viru
endotheli
cell
bridg
viral
cellular
glycan
glycan
bind
protein
present
initi
phase
infect
contrast
inhibit
viral
spread
ad
postinfect
garner
et
al
also
shown
promot
infect
crosslink
viral
particl
cell
entri
receptor
wherea
influenza
viru
infect
inhibit
stpierr
et
al
yang
et
al
alreadi
mention
sever
virus
specif
use
ctype
lectin
receptor
entri
transmiss
ebola
viru
util
array
differ
ctype
lectin
lsign
dcsign
lsectin
entri
variou
cell
type
lennemann
et
al
use
dcsign
dendrit
cell
migrat
cell
hong
et
al
although
entir
clear
balanc
antigen
present
transmiss
maintain
propos
homogen
highmannos
type
nglycan
enhanc
antigen
present
viru
degrad
compar
intrins
heterogen
nglycosyl
van
montfort
et
al
interestingli
also
shown
exploit
sialicacid
bind
lectin
effici
entri
macrophag
likewis
promot
exist
complextyp
nglycan
viral
particl
zou
et
al
similar
context
demonstr
vzv
bagdonait
et
al
hcmv
ebv
protein
backbon
depict
broken
black
line
space
repres
gap
align
individu
align
drawn
scale
indic
graph
sequenc
conserv
indic
align
sequenc
set
repres
greyscal
barcod
map
clustal
align
score
shown
legend
brief
clustal
align
score
asterisk
indic
posit
fulli
conserv
residu
colon
indic
conserv
amino
acid
strongli
similar
properti
wherea
period
indic
conserv
amino
acid
weakli
similar
properti
predict
signal
peptid
transmembran
region
shade
pink
blue
respect
unambigu
oglycosyl
site
shown
yellow
squar
wherea
ambigu
site
mark
yellow
line
within
protein
backbon
number
indic
number
glycosit
ambigu
oglycosyl
site
previou
public
bagdonait
et
al
gb
hexhexnac
omit
graph
exclud
possibl
could
part
elong
structur
adjac
site
refer
strain
sequenc
use
vzv
ebv
due
incomplet
unavail
annot
investig
strain
herp
simplex
viru
type
strain
herp
simplex
viru
type
strain
vzvvaricellazost
viru
strain
duma
hcmvhuman
cytomegaloviru
strain
town
ebvepsteinbarr
viru
strain
niemann
et
al
paramyxovirida
pneumoviru
ssrna
lambert
pon
gruber
levin
gruber
levin
c
lambert
pon
lambert
bernstein
et
al
earli
chemokinemedi
immun
respons
infect
vagin
mucosa
mice
reli
presenc
elong
olink
glycan
viral
particl
iversen
et
al
although
truncat
oglycan
might
benefit
viru
escap
earli
recognit
host
elong
oglycan
essenti
viral
replic
bagdonait
et
al
iversen
et
al
variou
carbohydr
structur
mani
bacteria
parast
worm
known
elicit
robust
innat
immun
respons
via
tolllik
receptor
rabinovich
toscano
prasanphanich
et
al
conceiv
analog
carbohydratemedi
mechan
could
exist
earli
detect
viral
infect
describ
detail
evolut
immun
system
develop
redund
finetun
mechan
identifi
elimin
invad
pathogen
includ
virus
turn
virus
continu
adapt
counteract
take
advantag
host
defens
mechan
ongo
battl
glycan
viral
glycoprotein
dual
role
virushost
interplay
figur
top
right
panel
one
hand
glycan
part
immun
determin
hand
glycan
mask
antigen
protein
epitop
recognit
alexand
elder
accumul
structur
evid
suggest
glycan
cover
larg
surfac
area
viral
envelop
protein
provid
steric
hindranc
physic
shield
vulner
site
wall
et
al
beniac
booth
nand
olink
glycan
mask
immunogen
bcell
epitop
case
also
determin
influenc
immunogen
sodora
et
al
hobman
et
al
fournilli
et
al
falkowska
et
al
hell
et
al
wang
et
al
bradeltretheway
et
al
nglycan
cover
structur
domain
function
region
often
confer
protect
neutral
hell
et
al
wang
et
al
bradeltretheway
et
al
wu
et
al
exampl
system
function
analysi
nglycosit
hcv
reveal
protect
nlink
glycan
mainli
situat
around
bind
site
hcv
envelop
glycoprotein
hell
et
al
case
remov
specif
nlink
glycan
alter
local
antigen
landscap
broaden
immun
respons
rather
simpli
uncov
underli
epitop
fournilli
et
al
wang
et
al
contrast
mutat
seemingli
unrel
nglycosit
reduc
sensit
neutral
distant
epitop
highlight
role
nglycan
maintain
protein
structur
conclus
mutat
potenti
nglycosyl
site
result
unpredict
effect
protein
tabl
glycan
chain
present
gener
viral
particl
illustr
manner
repres
glycoprofil
individu
virus
likewis
glycan
structur
shown
interact
specif
glycan
bind
molecul
repres
like
type
structur
high
mannos
complex
type
base
known
carbohydr
bind
specif
unless
specifi
otherwis
individu
studi
defin
interact
glycoprofilingglycoproteom
studi
virus
question
bottom
right
panel
virus
group
accord
predomin
mode
exit
within
individu
famili
viru
abbrevi
tabl
monosaccharid
symbol
follow
snfg
symbol
nomenclatur
glycan
system
pmid
glycobiolog
conform
molecular
dynam
differenti
affect
neutral
antibodi
explain
sole
epitop
recoveri
sitespecif
nglycosyl
also
report
affect
cellular
immun
hcv
delet
specif
glycan
enhanc
recognit
cytotox
cell
liu
et
al
dens
oglycosyl
viral
protein
wide
describ
provid
bulk
shield
host
immun
protect
antibodi
neutral
machiel
et
al
kropff
et
al
besid
shield
select
immunodomin
epitop
machiel
et
al
highli
oglycosyl
mucinlik
domain
found
ebola
marburg
virus
suggest
physic
hinder
interact
virusinfect
cell
immun
cell
francica
et
al
noyori
et
al
convers
delet
ebola
viru
mucinlik
domain
decreas
immun
respons
mice
although
effect
immunogen
vitro
dowl
et
al
final
oglycan
shield
case
present
part
neoepitop
elong
glycan
prevent
exampl
sever
oglycosyl
immunodomin
bcell
epitop
report
ebv
probe
oglycopeptid
sera
infect
patient
suggest
glycan
moieti
recogn
bcell
clo
et
al
darrigo
et
al
context
epitop
shield
immun
recognit
virus
might
import
rna
virus
influenza
viru
hcv
intrins
high
mutat
rate
thu
minim
effect
adapt
immun
respons
sanjuan
et
al
anjum
et
al
laur
et
al
lynch
et
al
earli
observ
highest
amino
acid
substitut
rate
occur
antigen
region
envelop
glycoprotein
includ
mutat
chang
number
posit
glycosyl
site
krystal
et
al
skehel
et
al
wei
et
al
due
high
densiti
glycan
region
carbohydr
chain
fulli
process
result
exposur
immatur
structur
seen
mannos
patch
hiv
door
bonomelli
et
al
paradox
underprocess
structur
recogn
immun
system
give
rise
broad
neutral
antibodi
bnab
classic
exampl
addit
highli
conserv
glycosyl
site
directli
involv
bind
cell
entri
receptor
viral
interact
partner
often
becom
target
bnab
rouvinski
et
al
interestingli
demonstr
recognit
bnab
larg
unaffect
delet
individu
nglycan
within
mannos
patch
mimick
consequ
intrins
mutagenesi
pritchard
spencer
et
al
case
howev
mutat
distant
glycosit
may
subtl
effect
epitop
recognit
behren
et
al
similarli
antigen
hbv
surfac
antigen
isoform
suffer
introduct
addit
nglycosyl
site
even
result
stronger
persist
immun
respons
hyakumura
et
al
contrast
arenavirus
repres
well
adapt
pathogen
glycan
shield
densiti
invers
correl
potenc
neutral
antibodi
sommerstein
et
al
howev
instanc
overglycosyl
import
function
region
viral
protein
result
better
shield
immun
system
cost
bind
affin
viru
product
aguilar
et
al
julith
et
al
lennemann
et
al
lynch
et
al
compromis
variabl
glycosit
occup
fulfil
requir
receptor
bind
via
nonglycosyl
protein
provid
protect
via
glycosyl
counterpart
julith
et
al
compon
viral
particl
expos
extracellular
environ
viral
envelop
glycoprotein
serv
major
target
vaccin
develop
howev
protein
sequenc
variabl
within
across
strain
high
mutat
rate
well
enorm
heterogen
glycan
structur
make
difficult
identifi
immunogen
evok
univers
reactiv
variou
express
system
use
product
subunit
vaccin
candid
bacteria
yeast
plant
insect
mammalian
cell
line
cox
kushnir
et
al
redkiewicz
et
al
glycosyl
type
replic
insect
mammalian
cell
yeast
cell
carri
mucin
type
oglycosyl
protein
produc
bacteri
cell
also
lack
nglycan
even
mammalian
express
system
may
lack
requir
glycosyltransferas
repertoir
glycosyl
relev
site
build
relev
structur
although
mani
success
exampl
vaccin
produc
aforement
system
quit
number
infecti
diseas
still
lack
vaccin
coverag
due
failur
vaccin
candid
induc
adequ
last
immun
respons
grimm
ackerman
therefor
cell
line
closer
natur
host
cell
type
explor
accur
reproduc
overal
protein
structur
modif
expos
antigen
site
prime
immun
system
abl
neutral
natur
encount
antigen
recent
effort
made
identifi
consensu
glycosyl
pattern
well
product
platform
lead
elicit
desir
immun
respons
pathogen
neutral
go
et
al
contrast
fast
mutat
rna
virus
dna
virus
includ
herpesvirus
rel
stabl
genom
reli
mean
counteract
host
immun
system
sanjuan
et
al
therefor
conceiv
vaccin
develop
less
challeng
dna
virus
howev
herpesvirustarget
subunit
vaccin
fail
far
recent
develop
vaccin
lack
main
neutral
antibodi
target
howev
show
great
promis
mice
vaccin
evok
product
nonneutr
antibodi
envelop
glycoprotein
infect
cell
stimul
cellular
nk
cell
immun
engag
receptor
petro
et
al
conclus
glycan
viral
envelop
glycoprotein
tremend
impact
recognit
host
glycosyl
heterogen
make
difficult
identifi
univers
vaccin
candid
experiment
evid
key
develop
accur
bioinformat
tool
predict
glycosyl
like
mutat
pattern
would
big
valu
vaccin
research
becom
possibl
substanti
number
viral
strain
sequenc
analyz
glycan
modif
nativ
context
nlink
glycan
situat
structur
domain
often
shield
function
import
protein
region
antibodi
neutral
stem
region
nglycan
affect
glycoprotein
stabil
proteinprotein
interact
exampl
mutat
nglycosit
local
stem
region
hendra
viru
glycoprotein
g
affect
conform
molecul
lead
increas
oligomer
interact
viral
bind
partner
bradeltretheway
et
al
moreov
stalk
mutat
similar
effect
close
relat
nipah
viru
bradeltretheway
et
al
hepat
c
viru
disrupt
specif
nglycosit
two
highli
nglycosyl
envelop
glycoprotein
result
format
unproduct
heterodim
meunier
et
al
goffard
et
al
orlova
et
al
wherea
specif
oglycosit
hendra
viru
protein
g
shown
affect
associ
protein
f
stone
et
al
suggest
type
glycan
carri
similar
function
similarli
oglycosit
found
region
varicella
zoster
viru
ge
import
interact
partner
gi
glycan
specif
function
yet
uncov
addit
hijack
host
glycosyl
machineri
modif
viral
protein
certain
virus
induc
chang
express
level
host
glycosyltransferas
exampl
document
herpesvirus
induc
express
host
fucosyltransferas
lead
express
sle
x
le
antigen
nystrom
et
al
norden
et
al
norden
et
al
addit
infect
lead
chang
gene
express
relat
glycosphingolipid
synthesi
miyaji
et
al
also
case
hcv
demonstr
total
glycoprofil
hcvinfect
hepatoma
cell
shift
toward
fucosyl
sialyl
gener
complex
nglycan
anoth
exampl
includ
hbv
shown
upregul
mannosidas
support
increas
glycan
process
case
influenza
viru
induct
isoform
detect
infect
respiratori
epitheli
cell
possibl
increas
oglycosyl
airway
mucin
chang
express
level
host
carbohydr
activ
enzym
either
hint
toward
requir
specif
structur
function
highlight
demand
increas
glycosyl
capac
support
viral
glycoprotein
glycosyl
long
known
glycosyl
viral
envelop
protein
essenti
infect
affect
immun
recognit
surprisingli
clinic
applic
develop
use
knowledg
glycosyl
rare
consid
vaccin
design
howev
awar
increas
studi
address
need
relev
glycosyl
vaccin
formul
go
et
al
rapidli
evolv
analyt
method
allow
precis
character
locat
structur
nand
olink
glycosyl
virus
likewis
advanc
glycobiolog
gene
edit
techniqu
offer
ampl
opportun
investig
function
role
glycan
structur
specif
site
unreli
predict
oglycosyl
discourag
sitespecif
analysi
oglycosyl
virus
structur
inform
obtain
high
throughput
glycoproteom
approach
well
bioinformat
analysi
glycosyl
pattern
serv
resourc
defin
target
studi
addit
knowledg
base
use
address
role
oglycosyl
antigen
immunogen
subunit
vaccin
candid
current
difficult
obtain
site
occup
inform
proteomewid
scale
soon
possibl
optim
target
glycoproteom
strategi
accumul
evid
suggest
oglysosyl
virus
play
import
role
variou
aspect
viru
biolog
advent
readili
avail
robust
genom
engin
tool
provid
opportun
investig
find
detail
map
structur
requir
oglycan
structur
viru
potenti
interact
partner
epitheli
cell
use
glycoengin
cell
librari
radhakrishnan
et
al
yang
et
al
challeng
howev
appli
knowledg
clinic
purpos
sinc
viral
glycosyl
orchestr
capac
host
cell
gener
glycosyl
inhibitor
limit
use
due
toxic
therefor
import
identifi
structur
determin
combinatori
selfand
nonselfnatur
safe
target
viral
glycan
boost
antivir
immun
envelop
virus
long
known
hijack
host
cell
glycosyl
machineri
glycosyl
viral
protein
develop
advanc
mass
spectrometri
techniqu
paid
tremend
contribut
character
precis
locat
structur
glycan
decor
viral
envelop
protein
reveal
substanti
heterogen
glycan
structur
site
occup
moreov
glycan
densiti
well
nto
oglycan
ratio
vari
greatli
among
differ
class
virus
highli
glycosyl
other
glycan
chain
accumul
sitedirect
mutagenesi
data
suggest
individu
glycosit
play
divers
import
role
viru
biolog
moreov
glycan
heavili
contribut
overal
structur
glycoprotein
epitop
access
case
directli
affect
immun
recognit
exampl
carbohydr
moieti
directli
particip
interact
mani
case
disrupt
biolog
function
result
impair
protein
structur
local
function
failur
develop
univers
vaccin
multipl
virus
hcv
hsv
suggest
comprehens
knowledg
structur
immunogen
viral
envelop
protein
relev
biolog
system
need
achiev
desir
immun
respons
locat
function
nlink
glycan
well
character
mani
virus
discoveri
oglycosit
neglect
due
natur
oglycan
synthesi
analyt
difficulti
develop
techniqu
global
address
sitespecif
oglycosyl
envelop
virus
reveal
unpreced
magnitud
oglycosyl
herpesvirus
argu
contribut
oglycan
need
address
vaccin
develop
order
complet
pictur
posttransl
modif
affect
protein
function
immunogen
hope
data
summar
review
ignit
interest
viral
oglycosyl
give
rise
focus
studi
lead
better
understand
viru
biolog
improv
mean
prevent
combat
associ
infect
